This company has been marked as potentially delisted and may not be actively trading. Artelo Biosciences (ARTLW) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Artelo Biosciences reports FY24 EPS $3.05 vs $3.14 last yearMarch 3, 2025 | markets.businessinsider.comEXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor ProgramJanuary 13, 2025 | benzinga.comAnalysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)December 9, 2024 | markets.businessinsider.comArtelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's "Preclinical Screening Platform for Pain" ProgramNovember 7, 2024 | stockhouse.comArtelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” ProgramNovember 6, 2024 | markets.businessinsider.comEF Hutton Initiates Coverage of Artelo Biosciences (ARTL) with Buy RecommendationOctober 2, 2024 | msn.comOptimistic Buy Rating for Artelo Biosciences Amidst Growing Focus on Cancer Cachexia TherapiesSeptember 18, 2024 | markets.businessinsider.comBuy Rating Affirmed for Artelo Biosciences on Strong Clinical Pipeline and Solid Financial HealthAugust 15, 2024 | markets.businessinsider.comArtelo Biosciences’ Drug Portfolio Progress Bolsters Buy Rating: Analyst Vernon Bernardino Forecasts Significant Clinical MilestonesAugust 15, 2024 | markets.businessinsider.comArtelo Biosciences: Strong Buy Rating on Clinical Advancement and Solid FinancialsMay 16, 2024 | markets.businessinsider.comARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024May 13, 2024 | investorplace.comArtelo Biosciences Inc.May 8, 2024 | wsj.comArtelo Biosciences Inc (ARTL)March 28, 2024 | uk.investing.comBuy Rating on Artelo Biosciences: Strong Pipeline and Market PotentialMarch 27, 2024 | markets.businessinsider.comARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023March 25, 2024 | investorplace.comRecap: Artelo Biosciences Q4 EarningsMarch 25, 2024 | benzinga.comArtelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeMarch 12, 2024 | finance.yahoo.comArtelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20thFebruary 15, 2024 | finance.yahoo.comArtelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyJanuary 23, 2024 | finance.yahoo.comArtelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNovember 30, 2023 | finance.yahoo.comArtelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNovember 9, 2023 | finance.yahoo.comPrincipal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaOctober 4, 2023 | finance.yahoo.comArtelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thSeptember 13, 2023 | finance.yahoo.comArtelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12September 7, 2023 | finance.yahoo.comArtelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thSeptember 6, 2023 | finance.yahoo.comArtelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 10, 2023 | finance.yahoo.comArtelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023July 19, 2023 | finance.yahoo.comArtelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11July 10, 2023 | finance.yahoo.comArtelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society SymposiumJune 28, 2023 | finance.yahoo.comArtelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In CanadaJune 26, 2023 | msn.comArtelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society SymposiumJune 26, 2023 | finance.yahoo.comArtelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society SymposiumJune 7, 2023 | finance.yahoo.comArtelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business UpdateMarch 31, 2023 | finance.yahoo.comArtelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossFebruary 2, 2023 | finance.yahoo.comArtelo Biosciences to Present at Sequire Biotechnology Conference on February 2ndJanuary 26, 2023 | finance.yahoo.comArtelo Biosciences, Inc. (ARTLW)September 1, 2022 | uk.finance.yahoo.comArtelo Biosciences Shares Up on Promising Antianxiety ResearchAugust 16, 2022 | marketwatch.comArtelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateAugust 9, 2022 | finance.yahoo.comArtelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossJuly 19, 2022 | finance.yahoo.comeFFECTOR Therapeutics, Inc. (EFTRW)July 14, 2022 | finance.yahoo.comArtelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, IrelandJune 24, 2022 | finance.yahoo.comArtelo Biosciences (NASDAQ:ARTLW), Short Interest ReportJune 13, 2022 | benzinga.comArtelo Biosciences to Present at the LD Micro Invitational XII on June 7thJune 1, 2022 | finance.yahoo.comArtelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thMay 13, 2022 | finance.yahoo.comArtelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 12, 2022 | finance.yahoo.com Remove Ads Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter. Email Address ARTLW Media Mentions By Week ARTLW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTLW News Sentiment▼0.000.61▲Average Medical News Sentiment ARTLW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTLW Articles This Week▼00▲ARTLW Articles Average Week Remove Ads Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRTSW News Today BCTXW News Today ENGNW News Today FBIOP News Today GOVXW News Today LEXXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARTLW) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTLW Stock Free ARTLW Stock Alerts